Lieber Jonathan I
- SEC CIK
- 0001350090
In the past year, 1 open-market sale filing worth $3.99K and no purchases.
Current role at each company
- DCOY Decoy Therapeutics Inc.Directoras of Sep 2, 2026
- RLYB Rallybio CorpChief Financial Officeras of Feb 23, 2026
- AGTC Applied Genetic Technologies CorpChief Financial Officeras of Dec 1, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.99K
- 1 filing
- Net
- −$3.99K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Lieber Jonathan I as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RLYB Rallybio Corp
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 (view filing) | Feb 23 | Same day | Lieber Jonathan IChief Financial Officer | SSale | −789 | $5.06 | −$3.99K | −16.1%4.12K after | |
| Mar 16, 2023 (view filing) | Mar 14 | 2 days | Lieber Jonathan ISee Remarks | PPurchase | +5.00K | $5.21 | +$26.1K | New position5.00K after |
DCOY Decoy Therapeutics Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2022 (view filing)3:12 PM ET | Jun 7 | 1 day | Lieber Jonathan IDirector | PPurchase | +37.5K | $0.1871 | +$7.02K | New position37.5K after |